                               SEQUENCE LISTING

<110> SAMPEN, HEE-JEONG IM
      AN, HOWARD S.
      CHEN, DI
 
<120> METHODS AND DEVICES FOR TREATING INTERVERTEBRAL DISC DISEASE

<130> B01859PCT/SYNT-5738

<140>
<141>

<150> 61/643,560
<151> 2012-05-07

<160> 24    

<170> PatentIn version 3.5

<210> 1
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      primer"

<400> 1
acccttcctt atcccttgat gcca                                              24


<210> 2
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      primer"

<400> 2
aaacagctct gcttcaacct gctg                                              24


<210> 3
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      primer"

<400> 3
agttcgacaa gtgcatggtg tgtg                                              24


<210> 4
<211> 25
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      primer"

<400> 4
atggtgacca cgttgttgta tccgt                                             25


<210> 5
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      primer"

<400> 5
tcaccagcat tgacgcatcc aaac                                              24


<210> 6
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      primer"

<400> 6
ttcgtggtag gtccagcaaa cagt                                              24


<210> 7
<211> 26
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      primer"

<400> 7
taaggatgcc tggcccttcc ttcaaa                                            26


<210> 8
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      primer"

<400> 8
ggccactgac aagtttcagg catt                                              24


<210> 9
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      primer"

<400> 9
accctggagc actcatgttt ccta                                              24


<210> 10
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      primer"

<400> 10
tggcatcaag ggataaggaa gggt                                              24


<210> 11
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      primer"

<400> 11
catcctgttg ttgctgtggc tgat                                              24


<210> 12
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      primer"

<400> 12
gcgtggatgc cgcatatgaa gtta                                              24


<210> 13
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      primer"

<400> 13
agtttgaatg ggcctttgag cacc                                              24


<210> 14
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      primer"

<400> 14
tagtccttgc cagggaaagt caca                                              24


<210> 15
<211> 22
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      primer"

<400> 15
atcacacgcc cacagagatc ca                                                22


<210> 16
<211> 22
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      primer"

<400> 16
gcttcaggct gttgagccat gt                                                22


<210> 17
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      primer"

<400> 17
gtaacccgtt gaaccccatt                                                   20


<210> 18
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      primer"

<400> 18
ccatccaatc ggtagtagcg                                                   20


<210> 19
<211> 23
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      primer"

<400> 19
atccattgga gggcaagtct ggt                                               23


<210> 20
<211> 26
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      primer"

<400> 20
gctcccaaga tccaactacg agcttt                                            26


<210> 21
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 21
Asp Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys 
1               5                   10                  15      


Lys Arg Asp Val Leu Pro Gly Thr 
            20                  


<210> 22
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 22
Arg Asp Val Leu Pro Gly Thr 
1               5           


<210> 23
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> misc_feature
<222> (1)..(1)
<223> /note="N-term Ac"

<220>
<221> misc_feature
<222> (7)..(7)
<223> /note="C-term NH2"

<400> 23
Arg Asp Val Leu Pro Gly Thr 
1               5           


<210> 24
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 24
Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


Arg Asp Val Leu Pro Gly Thr Cys Val Asn Ser 
            20                  25          

